Washington, D.C. 20549




Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934


Filed by the Registrant [X]   Filed by a Party other than the Registrant [  ]


Check the appropriate box:


[  ] Preliminary Proxy Statement
[  ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[  ] Definitive Proxy Statement
[X] Definitive Additional Materials
[  ] Soliciting Material Pursuant to Section 240.14a-12



(Name of Registrant as Specified in Its Charter)


Commission File Number: 001-33624


Not Applicable

(Name of Persons Filing Proxy Statement If Other Than the Registrant)


Payment of Filing Fee (Check the appropriate box):


[X] No fee required.
[  ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.


  1) Title of each class of securities to which transaction applies:
  2) Aggregate number of securities to which transaction applies:
  3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
  4) Proposed maximum aggregate value of transaction:
  5) Total fee paid:


[  ] Fee paid previously with preliminary materials.
[  ] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.


  1) Amount Previously Paid:
  2) Form, Schedule or Registration Statement No.:
  3) Filing Party:
  4) Date Filed:






On August 14, 2017, Amedica Corporation sent the following letter to its stockholders:




August 14, 2017


Dear Stockholder:


The important special meeting of the stockholders of Amedica Corporation has been adjourned, and is now scheduled to be held on September 7, 2017.


As more fully described in the proxy statement, your Board of Directors unanimously recommends that stockholders vote FOR the approval of an amendment to the Company’s Restated Certificate of Incorporation to effectuate a reverse stock split.


The purpose of the Reverse Stock Split is to increase the per share trading price of our Common Stock, which we believe would allow us to regain compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2).


Your vote is important, no matter how many or how few shares you may own. Please vote TODAY by telephone, via the Internet, or by signing, dating and returning the enclosed proxy card in the envelope provided.


Very truly yours,


B. Sonny Bal

Chairman of the Board and

    Chief Executive Officer